Cegedim Sa · EURONEXT:ALCGM
Cegedim Sa — Q1 2017 Earnings Presentation
29 slides from Cegedim Sa's earnings presentation, Apr 27, 2017
Slide 1: Cegedim Q1 2017 Revenue Conference Call
Cegedim 017 Revenue. Conference call dd ae cegedim April 27, 2017
Slide 2: First Quarter Revenue
7 we irst Quarter « avenue. oe
Slide 3: Agenda and Safe Harbor Statement
AGENDA 01 SAFE HARBOR STATEMENT ---------- This presentation contains forward- looking statements (made pursuant Cegedim Strategy to the safe harbour provisions of the Update Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty.
Slide 4: Cegedim Strategy: Update
» Cegedim Strategy: Update «K
Slide 5: Our Playbook
Our Playbook │5│ © Cegedim 2017
Slide 6: Our Playbook Planning
Our Playbook Planning │6│ © Cegedim 2017
Slide 7: 4 Growth Engines
4 Growth Engines │7│ © Cegedim 2017
Slide 8: Cegedim's Transformation
We have a clear vision for our future and are strongly positioned in key global market Cegedim’s Transformation Our playbook is underway and starting to deliver benefits 2017 is a turning point: sustainable future growth in revenue and earnings │8│ © Cegedim 2017
Slide 9: Financial Performance Q1-2017 Revenue
Financial Performance Q1-2017 Revenue
Slide 10: Q1-2017 Revenue
Group +6.9% The business model +4.8% transformation initiated in fall 2015 is €113.7m beginning to pay off +7.1% reported with acceleration +6.9% L-f-L Q1 2016 Q1 2017 Q1-2017 Health Insurance, HR & e-services +8.7% +12.5% All of the division’s Revenue activities contributed to the growth €68.6m +14
Slide 11: Q1-2017 Revenue growth by division
© Cegedi m 2017 +6.9% (1.3)% 1.5% €113.7m €106.2m +7.1% reported Q1 16 L-f-L Forex Structure Q1 17 Q1-2017 Revenue Revenue growth +14.9% (3.6)% n.s. €113.7m €106.2m Insurance , HR Activities not professionals & e-services Healthcare allocated Health Q1-16 Q1-17 │11│ Revenue growth by division © Cege
Slide 12: Focus on Organic Growth
Group Revenue +6.9% +5.4% +4.8% +4.9% +5.2% +2.4% Q1 16 Q2 16 Q3 16 Q4 16 … FY 16 Q1 17 Focus on Health Insurance, HR & e-services Revenue Organic +13.0% Growth +12.5% +10.3% +11.5% +8.7% +9.5% Q1 16 Q2 16 Q3 16 Q4 16 … FY 16 Q1 17 Healthcare Professionals Revenue +0.5% (6.3)% (0.7)% (4.2)% (2.7)% (
Slide 13: Well Diversified revenue source
Well Diversified revenue source │13│ © Cegedim 2017
Slide 14: BPO Development
│14│ 4,138 4,070 +68 3,893 +177 3,726 +167 3,439 +287 BPO Jun.15 Dec. 15 Jun. 16 Dec. 16 Mar. 17 Net hiring Development Workforce on long term contract €7.9m RCM Pulse SRH BPO +32% iGestion €6.0m +32% €4.6m Q1 15 Q1 16 Q1 17 BPO Revenue Trend © Cegedim 2017
Slide 15: Health Insurance, HR & e-services
+2.6% +12.5% €68.6m €59.7m (0.1)% 60.3% +14.9% reported Health Q1-16 L-f-L Forex Structure Q1-17 Insurance, HR % of Q1-17 Consolidated revenue Revenue growth & e-services Revenue • All of the division’s activities contributed to the growth • Double-digit growth at BPO business for health EMEA insura
Slide 16: Healthcare Professionals Revenue
€45.7m (0.9)% 38.7% (2.7)% 0.0% €44.0m (3.6)% reported Healthcare Q1-16 L-f-L Forex Structure Q1-17 Professionals % of Q1-17 Consolidated revenue Revenue growth Revenue • Decline in Q1-17 revenue was chiefly attributable to: • Transition to cloud-based offerings • Decline in doctor computerization r
Slide 17: FY 2017 Outlook Confirmed
FY 2017 Outlook » Confirmed «K
Slide 18: Potential impact of Brexit
In 2016, the UK represented 12.7% Of consolidated Group revenue Potential 14.8% impact of Of consolidated Group EBIT Brexit • Cegedim operates in the UK in local currency, as it does in all the countries where it operates. • No major European health program at work in the UK. Thus, the impact on the
Slide 19: FY 2017 Outlook Maintained
FY 2017 Revenue +4% / +6% L-f-l growth As of April 27, 2017 2017 €66m to €72m FY 2017 EBITDA As of April 27, 2017 Outlook Maintained • The business model transformation is well under way, so growth momentum is expected to pick up in Q4 2017 and lead to improving profitability in the future • We expe
Slide 20: Q&A Session
Q&A Session
Slide 21: Appendix
Appendix mi, cegedim
Slide 22: Cegedim Today: Our Clients
83% of FY 2016 revenue Cegedim Today: Our Clients 17% of FY 2016 revenue Proportional to FY 2016 Revenue • Software • Software • Services •Payroll • Database • BPO • BPO • Services • Third-party payment • TAM • Software • Database • Data • Services • Supply chain • Dematerialization • Supply chain •
Slide 23: Cegedim Today: Our division
Cegedim Today: Our division │23│ Proportional to FY 2016 Revenue (1) €4.0m adjustment to the Healthcare Professionals EBITDA © Cegedim 2017
Slide 24: Cegedim Today: Our Presence
Cegedim Today: Our Presence │24│ © Cegedim 2017
Slide 25: Cegedim Today: Our Strengths
Leading market positions Stable, well-balanced in each of our divisions and diversified revenue mix Cegedim Today: Unique presence Our Strengths High barriers to entry in the Healthcare Ecosystem Recognized portfolio of Long-standing shareholder innovative and integrated support and experienced solu
Slide 26: Cegedim Today: Our Positions
Cegedim Insurance Solutions Cegedim SRH Cegedim Today: Software and IT In France Third-Party Payment in France In France +350,000 employees managed everyday Our Positions Cegedim e-business Cegedim Healthcare Software +350 million UK Pharmacists European French, Italian French Pharmacists Electronic
Slide 27: Shareholder Structure as of Mar. 2017
Others 4% Shareholder BPI USA France 29% 34% Structure as 15.0% of Mar. 2017 Free float UK 33% 32.2% FCB 52.7% Source: IPREO Data on Sept. 26, 2016 Cegedim 0.2% │27│ © Cegedim 2017
Slide 28: Events 2017
EVENTS 2017 15 27 21 June July September Shareholders' Q2-17 Revenue HY-17 Earnings meeting 22 26 - September October - Analyst Q3-17 Revenue - Meeting © Cegedim 2017
Slide 29: Jan Eryk Umiastowski
Jan Eryk Umiastowski Chief Investment Officer – Head of Investor Relations janeryk.umiastowski@cegedim.com Tel: 00 33 1 49 09 33 36 – Mob: 00 33 6 73 25 96 34 © Cegedim 2017